Serious adverse reactions during dasatinib treatment
Dasatinib (Dasatinib), as a leukemia treatment drug, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of leukemia in adults and some children, including certain chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). However, like other powerful drugs, dasatinib can cause a range of serious side effects during treatment.
Some reported serious side effects include bone marrow suppression, which can cause a severe drop in a patient's blood cell count. Specifically, patients may develop extremely low levels of white blood cells (neutropenia) or severely insufficient levels of platelets (thrombocytopenia). These conditions usually do not show immediate symptoms but require prompt detection through a blood test ordered by your doctor. In addition, fever associated with a low white blood cell count (febrile neutropenia) is a serious side effect that requires special attention.
In addition to its effects on the blood system, dasatinib has the potential to cause serious skin reactions, including the rare but critical Stevens-Johnson syndrome. This syndrome presents with extensive damage to the skin and mucous membranes and requires prompt medical attention. In addition, tumor lysis syndrome, a potentially life-threatening disease caused by harmful chemicals released when large numbers of cancer cells die, is a potentially serious side effect.
Dasatinib may also cause serious eye-related side effects and severe allergic reactions. These reactions can vary from person to person, and the severity and duration can vary from person to person.
The side effects of dasatinib may vary depending on whether the drug is used alone or in combination with other chemotherapy drugs. Some side effects may be temporary, lasting only a few days to a few weeks. However, if side effects persist for an extended period of time, worsen symptoms, or cause significant distress to the patient, patients should inform their doctor immediately to seek necessary medical help and adjust their treatment plan.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)